Literature DB >> 12143206

Enhanced inflammatory cytokine production at ischemia/reperfusion in human liver resection.

Yang-Il Kim1, Kyung-Eun Song, Hun-Kyu Ryeon, Yoon-Jin Hwang, Young-Kook Yun, Jong-Won Lee, Byung-Yeol Chun.   

Abstract

BACKGROUND/AIMS: Clinical implications of acute reactant cytokine responses remain to be clarified in the setting of ischemia/reperfusion of human liver during liver resection and transplantation.
METHODOLOGY: In serial samples of portal and systemic venous blood we examined acute inflammatory cytokine activities at the time points--before i), at the end of clamping ii), and one hour iii) and day 1 iv) after continuous hepatic inflow occlusion in 25 patients undergoing elective hepatectomy (15 major and 10 minor). Responses of tumor necrosis factor-alpha, interleukin-1 beta, interleukin-6 and interleukin-8 were compared with intraoperative parameters such as the duration of hepatic inflow occlusion and portal venous pressure during the occlusion, postoperative hepatocyte injury markers such as serum transaminases and bilirubin and also related complications.
RESULTS: Portal interleukin-6 levels were significantly elevated during hepatic inflow occlusion, as compared with the systemic events (P < 0.02, at time point ii), but there were no differences in the interleukin-8 levels between the portal and systemic circulation. The increase in portal interleukin-6 levels during liver resection (time points, ii and iii) significantly correlated with the duration of hepatic inflow occlusion (48 +/- 9 min, mean +/- SD), portal venous pressure (500 +/- 127 mmH2O), and postoperative serum levels of transaminases (day 1; S-ALT, 705 +/- 1023 U/L; S-AST 892 +/- 1255 U/L) and maximum bilirubin (2.6 +/- 2.5 mg/dL). Interleukin-8 levels in the portal circulation showed no such correlation, but the levels in systemic blood showed significant positive relationships with the intra- and postoperative parameters. One patient who died had an enhanced generation of the cytokines in the presence of an elevated portal venous pressure.
CONCLUSIONS: These observations suggest that overproduction of acute reactant cytokines (interleukin-6 from the portal system and interleukin-8 from the systemic circulation) in hepatic ischemia/reperfusion relates positively with postoperative hepatocyte injury in humans. We propose that hepatectomy done under a prolonged continuous inflow occlusion should be reconsidered when an enhanced generation of acute cytokines is anticipated, especially in case of a markedly high portal pressure during hepatic pedicle clamping.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12143206

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  10 in total

Review 1.  Systematic review of pathophysiological changes following hepatic resection.

Authors:  Joey Siu; John McCall; Saxon Connor
Journal:  HPB (Oxford)       Date:  2013-08-29       Impact factor: 3.647

2.  Inhibition of TNF-α protects against hepatic ischemia-reperfusion injury in rats via NF-κB dependent pathway.

Authors:  Mona F Mahmoud; Shimaa M El Shazly; Waleed Barakat
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-02-08       Impact factor: 3.000

3.  Early post-operative measurement of cytokine plasma levels combined with pre-operative bilirubin levels identify high-risk patients after liver resection.

Authors:  Christoph W Strey; Rosa Maria Marquez-Pinilla; Maciej M Markiewski; Britta Siegmund; Elsie Oppermann; John D Lambris; Wolf O Bechstein
Journal:  Int J Mol Med       Date:  2010-12-28       Impact factor: 4.101

4.  Failure of P-selectin blockade alone to protect the liver from ischemia-reperfusion injury in the isolated blood-perfused rat liver.

Authors:  Samuel Wyllie; Neal R Barshes; Feng Qin Gao; Saul J Karpen; John A Goss
Journal:  World J Gastroenterol       Date:  2008-11-28       Impact factor: 5.742

5.  Major hepatectomy induces phenotypic changes in circulating dendritic cells and monocytes.

Authors:  Philip A Efron; Tadashi Matsumoto; Priscilla F McAuliffe; Philip Scumpia; Ricardo Ungaro; Shiro Fujita; Lyle L Moldawer; David Foley; Alan W Hemming
Journal:  J Clin Immunol       Date:  2009-04-22       Impact factor: 8.317

6.  Protective effects of tumor necrosis factor alpha antibody and ulinastatin on liver ischemic reperfusion in rats.

Authors:  Yan-Ling Yang; Ji-Peng Li; Xiao-Ping Xu; Ke-Feng Dou; Shu-Qiang Yue; Kai-Zong Li
Journal:  World J Gastroenterol       Date:  2004-11-01       Impact factor: 5.742

7.  Ischemic preconditioning confers antiapoptotic protection during major hepatectomies performed under combined inflow and outflow exclusion of the liver. A randomized clinical trial.

Authors:  Nikolaos Arkadopoulos; Georgia Kostopanagiotou; Kassiani Theodoraki; Charalambos Farantos; Theodosios Theodosopoulos; Vaia Stafyla; John Vassiliou; Dionyssios Voros; Agathi Pafiti; Vassilios Smyrniotis
Journal:  World J Surg       Date:  2009-09       Impact factor: 3.352

8.  Immunological Evaluation of Surgical Stress in Liver Resections.

Authors:  Alexandru Munteanu; Gabriel Samasca; Iulia Lupan; Cornel Iancu
Journal:  Maedica (Bucur)       Date:  2017-12

Review 9.  Angiogenesis in hepatocellular carcinoma: the retrospectives and perspectives.

Authors:  Hui-Chuan Sun; Zhao-You Tang
Journal:  J Cancer Res Clin Oncol       Date:  2004-03-18       Impact factor: 4.553

10.  Changes in gene expression of DOR and other thyroid hormone receptors in rat liver during acute-phase response.

Authors:  Ihtzaz Ahmed Malik; Bernhard G Baumgartner; Naila Naz; Nadeem Sheikh; Federico Moriconi; Giuliano Ramadori
Journal:  Cell Tissue Res       Date:  2010-10-15       Impact factor: 5.249

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.